EPIRUS Biopharmaceuticals, Inc.

699 Boylston Street, 11th Floor,
Boston, Massachusetts 02116
United States,
(617) 600-4313
www.epirusbiopharma.com

EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company, develops, manufactures and commercializes biosimilar therapeutics worldwide.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.4/yr) # - - 1 1 - - 2
vol $14M $14M
Sell (0.2/yr) # - - - 1 - - 1
vol $4M $4M
  3

Top M&A Advisors

Financial Deals
Sign-up to View
1
Legal Deals
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Bioceros BV
$14M (2015-09-09)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Zalicus Pharmaceuticals Ltd.
$4M (2015-10-14)

According to our data here at Mergr, EPIRUS Biopharmaceuticals has acquired 2 companies, including 2 in the last 5 years. It has also divested 1 asset.

EPIRUS Biopharmaceuticals’ largest acquisition to date was in 2015, when it acquired Bioceros BV for $14M. It’s largest disclosed sale occurred in 2015, when it sold Zalicus Pharmaceuticals to Taro Pharmaceuticals for $4M. EPIRUS Biopharmaceuticals has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 420 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 24 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to EPIRUS Biopharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.